icom_donate

Donate Today

icon_get_involved

Get Involved

icon_friend

Friends of

Osteosarcoma project secures further funding

A project researching the treatment and detection of osteosarcoma in children, funded for the past two years by Manchester-based charity, Friends of Rosie, has secured a further three years’ investment.

The project will continue at The University of Manchester, led by Dr Katherine Finegan. The next three years of funding, starting in October 2019, is being part-provided by Somerset-based charity, Hannah’s Willberry Wonder Pony. They provide funding specifically for osteosarcoma research.

What is osteosarcoma?

Osteosarcoma is a type of rare bone cancer. Once osteosarcoma has spread to other parts of a child’s body, called metastasizing, fewer than 30% of patients survive five years after diagnosis. The project to date has researched the role of a protein called, ERK5, which is believed to advance the spread of osteosarcoma tumours.

It is now understood that ERK5 controls the body’s immune response to tumours. During the initial research, Dr Finegan’s team found that by removing ERK5, they were able to slow the growth of osteosarcomas and prevent their spread to other parts of the body. The second phase of research, being part-funded by Hannah’s Willberry Wonder Pony, will build on these exciting preliminary findings to explore exactly how ERK5 controls osteosarcoma progression.

Dr Finegan comments, “We will focus now on trying to understand how ERK5-targeted therapies would work. We will also look to understand the proteins that “talk” and “listen” to ERK5 during osteosarcoma development, something we know nothing about yet. Understanding these “conversations” that ERK5 has in the cells, enables us to find new proteins that we could target in the future to make new therapies for osteosarcoma.”

Collaboration

Says Friends of Rosie Chair, Felicity Goodey, “We are delighted that our funding, which enabled this project to get off the ground, has already helped this vital research to secure further investment for the next three years. We are hopeful that this project will go on to attract large-scale funding and help to improve the prognosis and treatment for children diagnosed with osteosarcoma in the future.”

Rachel Francis of Hannah’s Willberry Wonder Pony Charity adds, “We’re delighted to be helping to take the very encouraging findings from the project funded by Friends of Rosie to the next stage. We’re working hard to collaborate with fellow charities and ensure our research activity is joined-up to ensure the greatest chance of success. We know Hannah would have been proud that her charity has enabled further research into this devastating disease.”

Notes to editors

About Friends of Rosie

When five-year-old Rosie Larkin lost her battle against cancer in 1991, her family and friends were determined to carry on the fight to help other children affected by cancer. They set up Friends of Rosie, an independent charity dedicated to raising money for research in Manchester into the causes, prevention, diagnosis and treatment of childhood cancer.

Friends of Rosie strongly believes that the key to cure is research and, with their supporters, they raise money in the North West of England for this underfunded and vital area of research.

As a volunteer-led charity, almost every penny raised is used as start-up funding for pioneering cancer research projects. Most of these research projects would never get off the ground without the charity’s support and many go on to be funded by national cancer research charities as a result.

About Hannah’s Willberry Wonder Pony Charity

Hannah’s Willberry Wonder Pony Charity was established by talented horse rider, Hannah Francis, following her diagnosis with the aggressive form of bone cancer in 2015. A major part of Hannah’s dream for her charity was to support vital research into osteosarcoma, which usually develops in growing bones. Hannah established her charity in March 2016 before tragically losing her life later that year at the age of just 18 years old.

Hannah founded her charity, Hannah’s Willberry Wonder Pony, in March 2016 to raise money to fulfil two principal objectives – to fund research into osteosarcoma and to provide equestrian experiences (“Willberry’s Wishes”) to seriously ill people. The charity made strong progress under Hannah’s leadership and has gone from strength to strength since her passing, raising more than £1,000,000 in its first 24 months. The charity has commenced a number of significant research programmes as Hannah so dearly wished and is granting Willberry’s Wishes to seriously ill people in the hope that these experiences inspire others in the same way as they did Hannah, bringing a little happiness and hope during the darkest of times.

Nancy Dykes

Nancy Dykes

Nancy, 11, was diagnosed with rhabdomyosarcoma when she was just 2 years old. She was treated with Proton Beam Therapy (PBT) in Germany but unfortunately relapsed less than a year later. The family were then sent to Germany for a second round of PBT. Although treatment helped to cure Nancy’s cancer, she has been left with lots of lasting effects which will require ongoing treatment throughout her life. Here Nancy and her mum, Antonia, share their story in the hope it will help others, raise awareness, and raise more money for children’s cancer research.

Prof John Hickman

Prof John Hickman

Why I am a Trustee of CCRF
 
I am a relative of the Larkin family and knew Rosie Larkin ( Friends of Rosie, now CCRF) when she had and then died of neuroblastoma, aged six. At that time, I was a scientist and professor at Manchester University, actively working on the problem of why some cancers do not die despite intensive and toxic therapies.  Seeing Rosie during her unsuccessful therapy and then attending her funeral, besides being emotional, drove me to double down on my own research as well as to support the Charity as best I could as a cancer researcher. I spent over a decade as the Chairman of the Scientific Advisory Board of the CCRF, when the Board moulded policies to ensure that funds raised for research into childhood cancers were distributed only to clinicians and researchers who had the brightest ideas that could impact of cancer medicine for children.
 
My role on the Board
 
As a Trustee,  I hope that my many decades of experience in cancer research and medicine can help the CCRF determine where best the funds that are raised can be invested in cutting edge research and medicine. I am also keen that the CCRF brings together UK and international experts in science and cancer medicine to brainstorm on how best to advance the treatment of childhood cancers.
 
My Background
 
I was a Professor of Pharmacology at Manchester University, working on drug resistance in cancer. I then moved to Paris, where I still live, to head cancer drug discovery at a French pharmaceutical company (Servier). I then headed an EU consortium for six years that brought together researchers from the pharmaceutical industry, universities and biotechnology companies, from all over Europe and the UK, to improve cancer drug discovery. I continue to be active in cancer health policy, publishing in the medical literature.
Katrina

Katrina London

Why I am a Trustee of CCRF

I have spent my professional career representing individuals and families affected by the devastating asbestos-related cancer, mesothelioma, which has no cure and for which there are only a limited number of palliative treatments available on the NHS.

I joined CCRF because I wanted to bring my understanding of the need to raise awareness of less well known cancers and passion for the need to secure improved funding for research to children facing a cancer diagnosis.

My role on the Board

I am responsible for oversight of our collaboration agreements with other charities to co-fund research into cures and treatments for childhood cancers. I also manage our challenge events and help with community fundraising. 

My Background

I am a Senior Associate at Irwin Mitchell LLP and specialise in Asbestos Disease Litigation, acting on behalf of victims of asbestos related diseases and their families.  Over the years, I have undertaken a number of fundraising challenges to raise money for cancer research, including a 1000 mile cycle ride from Glasgow to Southampton.   

Carla

Carla Nuttall

Why I’m a Trustee of CCRF
 
I became a trustee of the Children’s Cancer Research Fund because I believe every child deserves the chance to grow up healthy and with everything to look forward to in life. Like many people, I’ve seen the impact cancer can have on families and I wanted to do something that could make a real difference. This started through my work as an ambassador for Cyclists Fighting Cancer, which supported young people and their families in finding strength, confidence, and joy through movement.
 
That experience shaped my understanding of the challenges families face and the importance of community-led support – but crucially, the clear need for that to go hand-in-hand with targeted research and long-term solutions.
 
This is why I’m so passionate about the work CCRF does and proud to contribute to a cause that gives children and their families, the greatest chance of living a life without limits.
 
My Role on the Board
 
I support CCRF’s mission by bringing my experience in brand, marketing, and communications to the board. My focus is on helping CCRF tell its story in a way that resonates with people – whether that’s families, researchers, donors, or the wider public. I work alongside an incredible team to strengthen CCRF’s voice, build trust, and grow awareness so that more children and families can benefit from the breakthroughs we’re helping to fund.
 
My Background
 
I’m the Executive Director of Corporate Affairs and Marketing for The Growth Company, a social enterprise dedicated to helping people, businesses, and places to thrive through its market-leading insight, employment, skills and business support.
My passion is to help the organisations I work with to communicate with clarity, purpose, and integrity. That’s why I’ve spent my career in strategic communications supporting organisations that want to make a positive difference – CCRF could not fit my sense of purpose any better.